Medical termination of pregnancy at 63 to 83 days gestation.
Open Access
- 1 June 1999
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 106 (6) , 535-539
- https://doi.org/10.1111/j.1471-0528.1999.tb08320.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Early Pregnancy Termination with Mifepristone and Misoprostol in the United StatesNew England Journal of Medicine, 1998
- Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancyObstetrics & Gynecology, 1997
- The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK multicentre study—Final resultsContraception, 1997
- Termination of 2nd and 3rd trimester pregnancies with mifepristone and misoprostolEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of EdinburghBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal MisoprostolNew England Journal of Medicine, 1995
- Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation.BMJ, 1993
- Early Termination of Pregnancy with Mifepristone (RU 486) and the Orally Active Prostaglandin MisoprostolNew England Journal of Medicine, 1993
- Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprostContraception, 1993
- Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost)Contraception, 1989